Align Technology Inc.

ALGN ·Healthcare, Medical Devices, United States

Align Technology (ALGN)

Overview

Align Technology, Inc. is a global medical device company best known for the Invisalign system of clear aligners, along with iTero intraoral scanners and exocad computer-aided design/computer-aided manufacturing (CAD/CAM) software. It operates in the medical devices sector, within orthodontics and dental technology, and is headquartered in Tempe, Arizona (having relocated its global headquarters from San Jose, California). For fiscal year 2025, Align generated approximately $4.0 billion in total revenue and shipped roughly 2.6 million clear aligner cases, serving a base described by the company as more than 22 million Invisalign patients treated to date through a network of about 295,000 trained Invisalign doctors worldwide.

What They Do & How They Make Money

Align's business is built around treating malocclusion (misaligned teeth) and related orthodontic and restorative needs using a digital, non-metal-braces approach. The core product, Invisalign, is a series of custom, removable clear plastic aligners that gradually move a patient's teeth into position; each case is digitally planned using Align's ClinCheck software and manufactured to order, so revenue is generated primarily by selling aligner cases (and associated retainers) to orthodontists and general dentists, who in turn treat patients. Align also sells and services iTero intraoral scanners, which capture 3D digital impressions of a patient's mouth (replacing messy physical molds) and feed directly into aligner and restorative treatment planning, as well as exocad, dental CAD/CAM software used for restorative and orthodontic design. Scanner and software sales, along with recurring service, training, and CAD/CAM subscription revenue, make up its second reporting category. Align generates revenue from doctors and practices (its direct customers) rather than from patients directly, though it also runs consumer-facing marketing to build patient demand that doctors then convert into cases, and it increasingly offers financing and practice-support tools to make it easier for providers to adopt and scale Invisalign treatment.

Business Segments

Align reports its business primarily by product family rather than separate operating segments, in two main revenue categories:

Clear Aligner: Sale of Invisalign clear aligners and related products (including retainers) to orthodontists, general practice dentists, and international distributors. This is by far the larger category — about $3.245 billion of FY2025 revenue (roughly 81% of total), up modestly year over year on higher case volumes.
Imaging Systems and CAD/CAM Services: Sale and lease of iTero intraoral scanners and related services, plus exocad CAD/CAM software licenses and services. This category generated about $789.6 million in FY2025 (roughly 19% of total), growing faster than aligners in recent periods as scanner placements and software attach rates increase.

Within Clear Aligner, Align further distinguishes between "Comprehensive" (full orthodontic treatment) and "Non-Comprehensive" cases, and between adult, teen, and adolescent categories; management also discusses results by geography (Americas; EMEA — Europe, Middle East, Africa; and APAC — Asia-Pacific), with international markets increasingly driving growth alongside the maturing North American market.

Competitors

Clear aligners: SmileDirectClub-style direct-to-consumer brands (though SDC itself ceased operations in 2023), 3M's Clarity aligners, Straumann Group's ClearCorrect, Angelalign (a leading Chinese aligner maker with growing international ambitions), Envista's Spark aligners, and a large and growing field of lower-cost regional and generic clear-aligner manufacturers, particularly in China and other international markets.
Traditional orthodontics: Metal and ceramic braces remain a substitute treatment offered by orthodontists, representing the original alternative Align has spent two decades converting patients away from.
Imaging/scanners and CAD/CAM: Dentsply Sirona (Primescan), 3Shape (TRIOS scanners), Medit, Straumann, and various dental CAD/CAM software providers compete with iTero and exocad.

Competitive Position

Align pioneered the clear aligner category and still holds the largest share of the global clear aligner market, supported by strong brand recognition (Invisalign is often used generically for clear aligners), an extensive patent portfolio, deep integration between its scanners (iTero), design software (ClinCheck/exocad), and manufacturing operations, and a large installed base of trained doctors who have built their practices around the Invisalign workflow. Its scale advantages in manufacturing (Align produces enormous volumes of custom aligners) and its investments in AI-assisted treatment planning further reinforce switching costs for providers. However, the company faces intensifying competitive and pricing pressure, especially from lower-cost Chinese manufacturers such as Angelalign expanding internationally, as well as broader macro sensitivity: aligner treatment is often discretionary/elective spending that softens when consumer confidence weakens. Align's key patents have progressively expired, lowering barriers to entry, and it must continually invest in R&D, doctor training, and consumer marketing to defend share. Regulatory risk (FDA and international medical device rules), reliance on discretionary consumer spending, currency exposure from its large international business, and the cyclicality of teen/adult case volumes tied to economic conditions are ongoing risks to monitor.